Published in Dig Dis Sci on July 01, 2002
Blockade of adenosine A2B receptors ameliorates murine colitis. Br J Pharmacol (2008) 1.35
Impaired enterocyte proliferation in aquaporin-3 deficiency in mouse models of colitis. Gut (2007) 1.33
Substance P mediates antiapoptotic responses in human colonocytes by Akt activation. Proc Natl Acad Sci U S A (2007) 1.25
Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol (2010) 1.08
Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition. Dig Dis Sci (2007) 1.08
Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis. Clin Exp Immunol (2005) 1.07
β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway. Am J Pathol (2011) 1.05
Activator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis. Immunology (2004) 1.00
Inadequate clearance of translocated bacterial products in HIV-infected humanized mice. PLoS Pathog (2010) 1.00
Preventive and therapeutic euphol treatment attenuates experimental colitis in mice. PLoS One (2011) 0.95
Mechanisms of acupuncture and moxibustion in regulation of epithelial cell apoptosis in rat ulcerative colitis. World J Gastroenterol (2004) 0.93
Tauroursodeoxycholic acid inhibits experimental colitis by preventing early intestinal epithelial cell death. Lab Invest (2014) 0.88
ErbB2 and ErbB3 regulate recovery from dextran sulfate sodium-induced colitis by promoting mouse colon epithelial cell survival. Lab Invest (2011) 0.87
The role of zinc and metallothionein in the dextran sulfate sodium-induced colitis mouse model. Dig Dis Sci (2007) 0.87
Nuclear factor-kappaB is a critical mediator of Ste20-like proline-/alanine-rich kinase regulation in intestinal inflammation. Am J Pathol (2008) 0.86
Association of Fas-670 gene polymorphism with inflammatory bowel disease in Chinese patients. World J Gastroenterol (2005) 0.85
Suppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor γ expression. J Nutr Biochem (2011) 0.85
Dietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in mice. PLoS One (2013) 0.83
Expression of apoptosis-related proteins in rat with induced colitis. Int J Colorectal Dis (2004) 0.83
NHE3 modulates the severity of colitis in IL-10-deficient mice. Am J Physiol Gastrointest Liver Physiol (2011) 0.82
Mango polyphenolics reduce inflammation in intestinal colitis-involvement of the miR-126/PI3K/AKT/mTOR axis in vitro and in vivo. Mol Carcinog (2016) 0.82
Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans. FASEB J (2016) 0.81
Absence of stearoyl-CoA desaturase-1 does not promote DSS-induced acute colitis. Biochim Biophys Acta (2009) 0.81
Effects of a Lactobacillus reuteri BR11 mutant deficient in the cystine-transport system in a rat model of inflammatory bowel disease. Dig Dis Sci (2011) 0.80
Sodium arsenite reduces severity of dextran sulfate sodium-induced ulcerative colitis in rats. J Zhejiang Univ Sci B (2008) 0.80
Multifunctional activity of a small tellurium redox immunomodulator compound, AS101, on dextran sodium sulfate-induced murine colitis. J Biol Chem (2014) 0.79
Expression of apoptotic epithelial cells within lamina propria beneath the basement membrane triggers dextran sulfate sodium-induced colitis. Dig Dis Sci (2008) 0.78
AMP-18 Targets p21 to Maintain Epithelial Homeostasis. PLoS One (2015) 0.78
Inactivation of the p19(ARF) tumor suppressor affects intestinal epithelial cell proliferation and integrity. J Cell Biochem (2008) 0.78
Comparison of anti-inflammatory mechanisms of mango (Mangifera Indica L.) and pomegranate (Punica Granatum L.) in a preclinical model of colitis. Mol Nutr Food Res (2016) 0.78
Use of propolis hydroalcoholic extract to treat colitis experimentally induced in rats by 2,4,6-trinitrobenzenesulfonic Acid. Evid Based Complement Alternat Med (2013) 0.77
Mucosal injuries due to ribosome-inactivating stress and the compensatory responses of the intestinal epithelial barrier. Toxins (Basel) (2011) 0.75
Effect of karanjin on 2,4,6-trinitrobenzenesulfonic acid-induced colitis in Balb/c mice. Indian J Pharmacol (2017) 0.75
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology (1990) 11.22
Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest (1993) 10.09
Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology (1998) 9.58
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene (1994) 7.24
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol (1998) 5.77
Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol (1999) 2.92
Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim (1999) 2.20
Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut (1981) 2.08
Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis (2000) 1.95
Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res (1988) 1.93
High Fas ligand expression on lymphocytes in lesions of ulcerative colitis. Gut (1998) 1.88
CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology (1997) 1.81
Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol (1996) 1.73
Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut (1996) 1.60
The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis. Cancer (1996) 1.57
Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev (1999) 1.52
Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice. Gastroenterology (1998) 1.48
Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig Dis Sci (1999) 1.43
Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine. Am J Physiol (1997) 1.40
The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol (2000) 1.33
Chronic inflammatory bowel disease and cancer. Hepatogastroenterology (2000) 1.32
Changes in bacterial phagocytosis of macrophages in experimental ulcerative colitis. Digestion (1995) 1.22
Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am (1999) 1.19
[Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and changes in intestinal microflora]. Nihon Shokakibyo Gakkai Zasshi (1985) 1.10
Experimental models to study molecular mechanisms underlying intestinal inflammation. Ann N Y Acad Sci (1998) 1.09
Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium. Gut (1992) 1.08
Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl (1997) 1.04
Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis. Mod Pathol (1999) 1.03
Lessons from genetically engineered animal models. VII. Apoptosis in intestinal epithelium: lessons from transgenic and knockout mice. Am J Physiol Gastrointest Liver Physiol (2000) 1.02
Current theories on the causes of inflammatory bowel disease. Gastroenterol Clin North Am (1999) 1.00
Bax is downregulated in inflamed colonic mucosa of ulcerative colitis. Gut (2000) 0.97
Influence of topical rectal application of drugs on dextran sulfate-induced colitis in rats. Dig Dis Sci (1997) 0.97
The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats. Carcinogenesis (2000) 0.95
Increased stem cell somatic mutation in the non-neoplastic colorectal mucosa of patients with familial adenomatous polyposis. Hum Pathol (1998) 0.95
Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis. Int J Colorectal Dis (1999) 0.93
Abnormalities of epithelial apoptosis in multistep colorectal neoplasia demonstrated by terminal deoxyuridine nick end labeling. Dig Dis Sci (1996) 0.92
Morphological analysis of acute ulcerative colitis experimentally induced by dextran sulfate sodium in the guinea pig: some possible mechanisms of cecal ulceration. J Gastroenterol (1994) 0.85
Histochemical study of colonic cancer in experimental colitis of rats. Dig Dis Sci (1993) 0.84
Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis. Mol Pathol (1998) 0.83
[Study on the experimental ulcerative colitis (UC) model induced by dextran sulfate sodium (DSS) in rats (2)]. Nihon Yakurigaku Zasshi (1995) 0.79
Normal colonic mucosa in hereditary non-polyposis colorectal cancer shows no generalised increase in somatic mutation. Br J Cancer (1995) 0.78
Compensatory response of colon tissue to dextran sulfate sodium-induced colitis. J Gastroenterol (1999) 0.78
The development of animal models of inflammatory bowel disease. Int Rev Immunol (2000) 0.78
[Cell kinetics of carcinoma originating from rat colitis induced by dextran sulphate sodium]. Nihon Shokakibyo Gakkai Zasshi (1993) 0.75
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A (2012) 5.07
miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res (2012) 2.52
Human hepatic stem cell and maturational liver lineage biology. Hepatology (2011) 1.99
Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology (2006) 1.98
Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology (2011) 1.94
Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease. Hepatology (2012) 1.81
Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. Liver Transpl (2008) 1.65
Cholangiocarcinoma: update and future perspectives. Dig Liver Dis (2010) 1.58
Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol (2006) 1.57
Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. Am J Physiol Cell Physiol (2008) 1.57
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer Cell (2004) 1.54
Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. J Anat (2011) 1.51
The biliary tree--a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol (2012) 1.50
Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist. Inflamm Bowel Dis (2007) 1.46
Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium. Lab Invest (2009) 1.45
Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling. Gut (2009) 1.44
Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms. Proc Natl Acad Sci U S A (2008) 1.39
Association of Wwox with ErbB4 in breast cancer. Cancer Res (2007) 1.37
Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med (2009) 1.32
Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol (2004) 1.24
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Lab Invest (2007) 1.24
MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology (2005) 1.23
Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells. J Biol Chem (2008) 1.22
Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. Liver Int (2009) 1.21
Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol (2006) 1.20
Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. Endocrinology (2008) 1.19
The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. Am J Physiol Gastrointest Liver Physiol (2008) 1.18
Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res (2008) 1.18
Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation. Hepatology (2010) 1.17
Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression. Cancer Res (2010) 1.16
Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. Am J Physiol Gastrointest Liver Physiol (2007) 1.15
Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology (2002) 1.15
After damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes. Am J Pathol (2010) 1.13
Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy. J Clin Virol (2008) 1.13
Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor. Int J Cancer (2010) 1.12
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. Am J Pathol (2008) 1.12
The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. J Hepatol (2005) 1.12
Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma. Gut (2011) 1.08
Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1. Am J Physiol Gastrointest Liver Physiol (2009) 1.08
Cellular and molecular mechanisms of intestinal fibrosis. World J Gastroenterol (2012) 1.07
H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo. Mol Cancer Res (2009) 1.06
Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis. Int J Cancer (2009) 1.04
Concise review: clinical programs of stem cell therapies for liver and pancreas. Stem Cells (2013) 1.03
Small intestine contrast ultrasonography: an alternative to radiology in the assessment of small bowel disease. Inflamm Bowel Dis (2005) 1.03
Biliary tree stem cells, precursors to pancreatic committed progenitors: evidence for possible life-long pancreatic organogenesis. Stem Cells (2013) 1.02
GFAP expression in the liver as an early marker of stellate cells activation. Ital J Anat Embryol (2006) 1.02
Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med (2004) 1.02
Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms. Am J Physiol Gastrointest Liver Physiol (2008) 1.00
Catheter-related candidemia caused by Candida lipolytica in a patient receiving allogeneic bone marrow transplantation. J Clin Microbiol (2002) 1.00
Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis. DNA Cell Biol (2006) 0.99
Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis. Ann Intern Med (2007) 0.98
Multipotent stem/progenitor cells in the human foetal biliary tree. J Hepatol (2012) 0.98
Prevention of fibrosis in experimental colitis by captopril: the role of tgf-beta1. Inflamm Bowel Dis (2004) 0.98
Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis. J Histochem Cytochem (2006) 0.97
Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. Gastroenterology (2002) 0.97
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growth. Am J Physiol Gastrointest Liver Physiol (2011) 0.94
Multipotent stem cells in the biliary tree. Ital J Anat Embryol (2010) 0.94
Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors. Am J Physiol Gastrointest Liver Physiol (2011) 0.93
Prolactin stimulates the proliferation of normal female cholangiocytes by differential regulation of Ca2+-dependent PKC isoforms. BMC Physiol (2007) 0.93
Retracted Targeted disruption of the murine homeodomain-interacting protein kinase-2 causes growth deficiency in vivo and cell cycle arrest in vitro. DNA Cell Biol (2009) 0.93
Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity. World J Gastrointest Oncol (2012) 0.93
Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks. Int J Mol Sci (2013) 0.93
Taurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression. Exp Biol Med (Maywood) (2009) 0.92
PRMT5 is upregulated in malignant and metastatic melanoma and regulates expression of MITF and p27(Kip1.). PLoS One (2013) 0.92
BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo. Clin Cancer Res (2008) 0.91
Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy. Antioxid Redox Signal (2011) 0.91
Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma. Int J Cancer (2010) 0.91
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. Dig Liver Dis (2011) 0.91
Revascularization and remodelling of pancreatic islets grafted under the kidney capsule. J Anat (2007) 0.89
99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease. Eur J Nucl Med Mol Imaging (2003) 0.89
Recent advances in the morphological and functional heterogeneity of the biliary epithelium. Exp Biol Med (Maywood) (2013) 0.89
Modulation of the biliary expression of arylalkylamine N-acetyltransferase alters the autocrine proliferative responses of cholangiocytes in rats. Hepatology (2013) 0.88
Activation of alpha(1) -adrenergic receptors stimulate the growth of small mouse cholangiocytes via calcium-dependent activation of nuclear factor of activated T cells 2 and specificity protein 1. Hepatology (2011) 0.88
Vascular factors, angiogenesis and biliary tract disease. Curr Opin Gastroenterol (2010) 0.88
Morphological changes of isolated rat pancreatic islets: a structural, ultrastructural and morphometric study. J Anat (2006) 0.88
Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis. Dig Liver Dis (2010) 0.88
Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression. Liver Int (2009) 0.87
The fascial structures of the rectum and the "so-called mesorectum": an anatomical or a terminological controversy? Surg Radiol Anat (2009) 0.87
The challenge of reform: 10 years of curricula change in Italian medical schools. Med Teach (2009) 0.86
Prostate apoptosis response-4 is expressed in normal cholangiocytes, is down-regulated in human cholangiocarcinoma, and promotes apoptosis of neoplastic cholangiocytes when induced pharmacologically. Am J Pathol (2010) 0.86
Mucin-producing cholangiocarcinoma might derive from biliary tree stem/progenitor cells located in peribiliary glands. Hepatology (2012) 0.86
Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanisms. Lab Invest (2011) 0.86
Current management of severe ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol (2007) 0.84
Self-reported milk intolerance in irritable bowel syndrome: what should we believe? Clin Nutr (2004) 0.84
GABA induces the differentiation of small into large cholangiocytes by activation of Ca(2+) /CaMK I-dependent adenylyl cyclase 8. Hepatology (2013) 0.84
Monthly and seasonal birth patterns and the occurrence of Crohn's disease. Am J Gastroenterol (2009) 0.84
Ferritin as a simple indicator of iron deficiency in anemic IBD patients. Inflamm Bowel Dis (2006) 0.83
Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation. ACS Chem Biol (2013) 0.83
Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing. J Crohns Colitis (2011) 0.83
Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity. ACS Chem Biol (2012) 0.83
Neuroanatomy and cadaver dissection in Italy: History, medicolegal issues, and neurosurgical perspectives. J Neurosurg (2006) 0.83
Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception. Inflamm Bowel Dis (2008) 0.82
Regulation of biliary proliferation by neuroendocrine factors: implications for the pathogenesis of cholestatic liver diseases. Am J Pathol (2011) 0.82
Tamoxifen in treatment of primary biliary cirrhosis. Hepatology (2004) 0.82